{"id":1014,"date":"2025-09-29T16:18:33","date_gmt":"2025-09-29T13:18:33","guid":{"rendered":"http:\/\/covid19.tubitak.gov.tr\/?p=1014"},"modified":"2025-10-08T16:15:02","modified_gmt":"2025-10-08T13:15:02","slug":"bilgi-gunu-pandemideki-tecrubeler-ve-tubitak-tusebin-ar-ge-is-birlikleri","status":"publish","type":"post","link":"https:\/\/covid19.tubitak.gov.tr\/en\/bilgi-gunu-pandemideki-tecrubeler-ve-tubitak-tusebin-ar-ge-is-birlikleri\/","title":{"rendered":"SciREACT 6. Bilgi G\u00fcn\u00fc’nde: Pandemideki Tecr\u00fcbeler ve T\u00dcB\u0130TAK-T\u00dcSEB\u2019in AR-GE \u0130\u015f Birlikleri"},"content":{"rendered":"
\n

Pandemi s\u00fcrecinde edinilen bilimsel ve teknik tecr\u00fcbeler ve T\u00dcB\u0130TAK-T\u00dcSEB’in Ar-Ge i\u015f birliklerinin \u00f6nemi ve gelece\u011fe y\u00f6nelik stratejik yol haritalar\u0131 de\u011ferlendirildi.<\/p>\n\n\n\n

\"\"<\/figure>\n<\/blockquote>\n\n\n\n

T\u00fcrkiye ve Avrupa Birli\u011fi ortakl\u0131\u011f\u0131nda y\u00fcr\u00fct\u00fclen COVID-19\u2019a Kar\u015f\u0131 Bilimsel Yan\u0131t (SciREACT) Projesi\u2019nin 6. Bilgi G\u00fcn\u00fc, 8 May\u0131s 2025 tarihinde T\u00dcSEB Aziz Sancar Ara\u015ft\u0131rma Merkezi Konferans Salonu\u2019nda hibrit (fiziksel ve \u00e7evrimi\u00e7i) formatta ger\u00e7ekle\u015ftirildi. Pandemi s\u00fcrecinde edinilen bilimsel, teknik ve y\u00f6netsel tecr\u00fcbeler ile T\u00dcB\u0130TAK-T\u00dcSEB\u2019in Ar-Ge i\u015f birliklerine dair stratejik yakla\u015f\u0131mlar, i\u015f birli\u011fi modelleri ve \u00f6rnek projelerin payla\u015f\u0131ld\u0131\u011f\u0131 etkinlik, sekt\u00f6r\u00fcn \u00f6nde gelen uzmanlar\u0131 ve akademisyenlerini bir araya getirdi.<\/p>\n\n\n\n

Program\u0131n a\u00e7\u0131l\u0131\u015f konu\u015fmalar\u0131, T\u00dcSEB Biyoteknoloji Enstit\u00fcs\u00fc Ba\u015fkan\u0131 Prof. Dr. Duygu \u00d6zel Demiralp, T\u00dcB\u0130TAK MAM BYIYB Biyoteknoloji AG Lideri Lideri Do\u00e7. Dr. Hilal Yaz\u0131c\u0131 Malko\u00e7o\u011flu, T\u00dcSEB A\u015f\u0131 Enstit\u00fcs\u00fc Ba\u015fkan\u0131 Prof. Dr. Ate\u015f Kara ve T\u00dcB\u0130TAK Marmara Ara\u015ft\u0131rma Merkezi Ba\u015fkan Yard\u0131mc\u0131s\u0131 Vekili Do\u00e7 Dr. \u00d6zgen Ercan taraf\u0131ndan yap\u0131ld\u0131. Konu\u015fmalarda, pandemi s\u00fcrecinde edinilen bilimsel ve teknik tecr\u00fcbeler ile T\u00dcB\u0130TAK-T\u00dcSEB\u2019in Ar-Ge i\u015f birlikleri, geli\u015ftirdi\u011fi i\u015f modelleri ve projelerin hem ulusal bilimsel \u00fcretime hem de s\u00fcrd\u00fcr\u00fclebilir bilimsel altyap\u0131n\u0131n g\u00fc\u00e7lendirilmesine katk\u0131s\u0131 vurguland\u0131.<\/p>\n\n\n\n

Program\u0131n ilk oturumunda, T\u00dcB\u0130TAK MAM Biyoteknoloji Ara\u015ft\u0131rma Grubu Lideri Do\u00e7. Dr. Hilal Yaz\u0131c\u0131 Malko\u00e7o\u011flu, SciREACT projesi kapsam\u0131nda y\u00fcr\u00fct\u00fclen \u00e7al\u0131\u015fmalar\u0131 ve pandemi d\u00f6neminde elde edilen bilimsel \u00e7\u0131kt\u0131lar ve kazan\u0131mlar\u0131 anlatt\u0131. Ayr\u0131ca, bu deneyimlerin gelecekteki ulusal Ar-Ge stratejilerine ve kamu-\u00f6zel sekt\u00f6r i\u015f birli\u011fi modellerinin geli\u015ftirilmesine katk\u0131s\u0131n\u0131 kat\u0131l\u0131mc\u0131larla payla\u015ft\u0131.<\/p>\n\n\n\n

Program\u0131n devam\u0131nda, Prof. Dr. Sibel Ay\u015f\u0131l \u00d6zkan, pandemi d\u00f6neminde geli\u015ftirilen molek\u00fcler tan\u0131 kitleri ve sens\u00f6r sistemlerindeki yenilik\u00e7i yakla\u015f\u0131mlar\u0131 anlatt\u0131. H\u0131zl\u0131 tan\u0131, ta\u015f\u0131nabilirlik ve hassasiyet gibi parametrelerdeki bu yeniliklerin, yerli \u00fcretim kapasitesini art\u0131rma ve sens\u00f6r tabanl\u0131 sistemlerin erken uyar\u0131 mekanizmalar\u0131nda kullan\u0131m\u0131 a\u00e7\u0131s\u0131ndan \u00f6nemini vurgulad\u0131. Ard\u0131ndan T\u00dcSEB Biyoteknoloji Enstit\u00fcs\u00fc\u2019nden Dr. Tun\u00e7 Tuncel, \u201cT\u00fcrkiye Ulusal Genom ve Biyoinformatik Projesi\u201d ba\u015fl\u0131kl\u0131 sunumunda, ulusal genom verilerinin sa\u011fl\u0131k sistemine entegrasyonu, biyoinformatik altyap\u0131n\u0131n geli\u015ftirilmesi ve yapay zek\u00e2 destekli analizlerin tan\u0131 ve tedavi s\u00fcre\u00e7lerine katk\u0131s\u0131 \u00fczerine bilgi verdi.<\/p>\n\n\n\n

Turkovac ve Klinik \u00c7al\u0131\u015fmalar\u201d ba\u015fl\u0131kl\u0131 sunumunda, T\u00dcSEB A\u015f\u0131 Enstit\u00fcs\u00fc Ba\u015fkan\u0131 Prof. Dr.<\/a> Ate\u015f Kara, TURKOVAC a\u015f\u0131s\u0131n\u0131n geli\u015ftirilme s\u00fcrecini, Ar-Ge\u2019den \u00fcretime kadar olan bilimsel ve idari boyutlar\u0131 ile elde edilen ba\u015far\u0131lar\u0131 detayl\u0131 \u015fekilde anlatt\u0131. T\u00dcSEB Biyoteknoloji Enstit\u00fcs\u00fc Ba\u015fkan\u0131 Prof. Dr. Duygu \u00d6zel Demiralp ise, \u201cDiaKit\u201d ba\u015fl\u0131kl\u0131 sunumunda, DiaKit\u2019in geli\u015ftirilme s\u00fcreci, teknolojik bile\u015fenleri, uygulamalar\u0131 ve pandemi s\u00fcrecindeki yerini; tan\u0131 s\u00fcrecindeki do\u011fruluk, h\u0131z ve maliyet etkinli\u011fi a\u00e7\u0131s\u0131ndan sundu\u011fu avantajlarla birlikte de\u011ferlendirdi.<\/p>\n\n\n\n

\u00d6\u011fleden sonraki oturumlar\u0131n ilk konu\u015fmas\u0131n\u0131 Ege \u00dcniversitesi\u2019nden Prof. Dr. Mert D\u00f6\u015fkaya ger\u00e7ekle\u015ftirdi. \u201cDNA A\u015f\u0131s\u0131n\u0131n GMP \u00dcretimine Y\u00f6nelik \u00d6l\u00e7ek B\u00fcy\u00fctme Optimizasyon \u00c7al\u0131\u015fmalar\u0131\u201d ba\u015fl\u0131kl\u0131 sunumunda, DNA a\u015f\u0131lar\u0131n\u0131n \u00fcretim altyap\u0131s\u0131nda GMP uyumlulu\u011fu sa\u011flamak i\u00e7in ger\u00e7ekle\u015ftirilen optimizasyon \u00e7al\u0131\u015fmalar\u0131yla birlikte kar\u015f\u0131la\u015f\u0131lan teknik zorluklar ve \u00e7\u00f6z\u00fcm \u00f6nerilerini payla\u015ft\u0131. Prof. Dr. Mehmet \u0130nan \u201cCOVID-19\u2019a kar\u015f\u0131 Rekombinant Protein Temelli A\u015f\u0131 Geli\u015ftirme \u00c7al\u0131\u015fmalar\u0131\u201d ba\u015fl\u0131kl\u0131 sunumunda, rekombinant protein temelli a\u015f\u0131lar\u0131n tasar\u0131m\u0131, geli\u015ftirme s\u00fcreci, preklinik sonu\u00e7lardan elde edilen bilimsel \u00e7\u0131kt\u0131lar ve kar\u015f\u0131la\u015f\u0131lan teknik zorluklar hakk\u0131nda kat\u0131l\u0131mc\u0131lara bilgi verdi. T\u00dcB\u0130TAK MAM Biyoteknoloji Ara\u015ft\u0131rma Grubu\u2019ndan Dr. M\u00fcge Serhatl\u0131 ise \u201cCOVID-19 S\u00fcrecinde Biyofarmas\u00f6tik Tekniklerin Geli\u015fimi ve Kullan\u0131m\u0131\u201d ba\u015fl\u0131kl\u0131 sunumunda, pandemide h\u0131z kazanan biyofarmas\u00f6tik tekniklerin geli\u015fimi ve uygulama alanlar\u0131n\u0131 anlatarak, bu s\u00fcre\u00e7lerin gelecekteki krizlere haz\u0131rl\u0131k kapasitesini nas\u0131l art\u0131rd\u0131\u011f\u0131n\u0131 ortaya koydu.<\/p>\n\n\n\n

Program\u0131n kapan\u0131\u015f oturumunda, T\u00dcSEB Teknoloji Transfer Ofisi\u2019nden Do\u00e7. Dr. Zeliha \u00d6zdemir K\u00f6ken, \u201cCOVID-19 Pandemi S\u00fcrecinde Teknoloji Transfer Ofislerinin Faaliyetlerindeki De\u011fi\u015fim ve Geli\u015fim\u201d ba\u015fl\u0131kl\u0131 sunumunda, pandemi d\u00f6neminde teknoloji transfer ofislerinin de\u011fi\u015fen rol\u00fc ve bu s\u00fcre\u00e7teki geli\u015fimini ele ald\u0131. Etkinlikteki konu\u015fmalar\u0131n ard\u0131ndan yap\u0131lan de\u011ferlendirme oturumunda, kat\u0131l\u0131mc\u0131lar COVID-19 pandemisi s\u00fcresince edinilen bilimsel ve teknolojik tecr\u00fcbeleri ele alarak, yerli tan\u0131 kitleri ve a\u015f\u0131 projelerinin yan\u0131 s\u0131ra biyofarmas\u00f6tik tekniklerin geli\u015fimi ve kullan\u0131m\u0131 ile teknoloji transfer ofislerinin faaliyetlerindeki de\u011fi\u015fim ve d\u00f6n\u00fc\u015f\u00fcm \u00fczerine g\u00f6r\u00fc\u015f al\u0131\u015fveri\u015finde bulundular. T\u00dcB\u0130TAK ve T\u00dcSEB\u2019in \u00f6nc\u00fcl\u00fc\u011f\u00fcnde geli\u015ftirilen Ar-Ge i\u015f birliklerinin, kriz d\u00f6nemlerinde h\u0131zl\u0131 \u00e7\u00f6z\u00fcm \u00fcretme, ulusal kapasite olu\u015fturma ve s\u00fcrd\u00fcr\u00fclebilir bilimsel altyap\u0131 in\u015fa etme s\u00fcre\u00e7lerindeki rol\u00fc vurguland\u0131. Kat\u0131l\u0131mc\u0131lar, pandemi d\u00f6neminden elde edilen kazan\u0131mlar\u0131n, gelecekteki sa\u011fl\u0131k tehditlerine kar\u015f\u0131 daha haz\u0131rl\u0131kl\u0131 ve dayan\u0131kl\u0131 bir ara\u015ft\u0131rma ekosistemi kurulmas\u0131na katk\u0131 sa\u011flad\u0131\u011f\u0131 konusunda ortak bir perspektif geli\u015ftirdiler.<\/p>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n<\/figure>","protected":false},"excerpt":{"rendered":"

T\u00fcrkiye ve Avrupa Birli\u011fi ortakl\u0131\u011f\u0131nda y\u00fcr\u00fct\u00fclen COVID-19\u2019a Kar\u015f\u0131 Bilimsel Yan\u0131t (SciREACT) Projesi\u2019nin 6. Bilgi G\u00fcn\u00fc, 8 May\u0131s 2025 tarihinde T\u00dcSEB Aziz Sancar Ara\u015ft\u0131rma Merkezi Konferans Salonu\u2019nda hibrit (fiziksel ve \u00e7evrimi\u00e7i) formatta ger\u00e7ekle\u015ftirildi. Pandemi s\u00fcrecinde edinilen bilimsel, teknik ve y\u00f6netsel tecr\u00fcbeler ile T\u00dcB\u0130TAK-T\u00dcSEB\u2019in Ar-Ge i\u015f birliklerine dair stratejik yakla\u015f\u0131mlar, i\u015f birli\u011fi modelleri ve \u00f6rnek projelerin payla\u015f\u0131ld\u0131\u011f\u0131 […]<\/p>","protected":false},"author":3,"featured_media":1015,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-1014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-duyurular"],"_links":{"self":[{"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/posts\/1014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/comments?post=1014"}],"version-history":[{"count":3,"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/posts\/1014\/revisions"}],"predecessor-version":[{"id":1035,"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/posts\/1014\/revisions\/1035"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/media\/1015"}],"wp:attachment":[{"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/media?parent=1014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/categories?post=1014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/covid19.tubitak.gov.tr\/en\/wp-json\/wp\/v2\/tags?post=1014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}